Due to rising demand for industry products, and historic inaccessibility to a number of high-quality human biospecimens, the Cryogenic Biobanking Services industry has performed exceptionally well over the five years to 2013. While industry operators have faced a number of challenges over this period, particularly with regard to funding, rising research and development expenditure and the mounting importance disease researchers place on biospecimens, the industry continued to grow rapidly. Furthermore, although the increasing size of the industry is expected to draw ethical questions related to current practices, attracting attention from regulators, and issues concerning the ownership rights of biospecimens will become more prevalent, industry revenue will not be greatly impacted by these trends, continuing to increase rapidly in the five years to 2018.
This industry operates cryogenic storage facilities used to archive biological samples used for research. Biobanks, or repositories that store these biological samples, are used in hospitals, universities, nonprofit organizations and pharmaceutical companies.
The report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecast, growth rates and an analysis of the industry key players and their market shares.